Search

everythinglearnresearchcommunity

for

Search:↓

Infliximab improved skin and bowel symptoms in Crohn's disease but caused side effects and the disease returned after stopping treatment.

Sunlight exposure improved a patient's skin condition, and there may be a link between a certain disease and skin growths; a leukemia treatment caused changes in hair color and growth.

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.

Pediatricians should treat some hair loss types in children and refer others to a dermatologist.

A dog with unusual skin lesions near its tail was successfully treated for a rare form of lupus.

A woman with a rare type of dermatomyositis improved with low-dose prednisone and methotrexate.

Interleukin-2 treatment improved hair growth, sexual function, and reduced fungal infection in a patient with thymoma-related symptoms.

New regenerative treatments for hair loss show promise but need more research for confirmation.

The article concludes that different types of hair loss require specific treatments and psychological support is important.

Some children with localized scleroderma are rarely resistant to methotrexate, and no common profile for resistance was found.

Scalp biopsies are crucial for diagnosing hair loss causes in cutaneous lymphoma patients.

Managing multiple autoimmune diseases in one patient is extremely challenging.

Most treatments for Frontal Fibrosing Alopecia are ineffective, but early anti-inflammatory therapy may help and the condition may stabilize over time.

Ciclosporin might be a good alternative treatment for certain hearing loss that responds to steroids.

New treatments for vitiligo show promise but still face challenges, especially for hands and feet.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

Hair loss from alopecia areata and androgenetic alopecia can be treated, but more effective and safer treatments are needed.

Early treatment of fibrosing alopecia in a pattern distribution may improve outcomes.

New targeted cancer drugs can cause skin side effects, and managing them requires patient education and timely care.

A rare autoimmune condition, Satoyoshi syndrome, can start in adults and improve with immunosuppressive treatment.

New treatments for Frontal Fibrosing Alopecia show promise, especially finasteride and dutasteride, with most patients seeing improvement or stabilization.

Hair transplantation for Frontal Fibrosing Alopecia may work if done after the disease is inactive for 2 years and with ongoing treatment after surgery.

A man with multiple autoimmune diseases developed liver injury from azathioprine, but his liver improved after stopping the drug.

A woman with leprosy improved after stopping dapsone and getting treatment for a severe skin reaction and nail changes.

The document concludes that accurate diagnosis of alopecia in children relies on thorough examination and history, and while treatments exist, none can alter the course of alopecia areata, which can significantly affect a child's psychological well-being.

Hair transplant surgeons did not agree on which drugs to use except for local anesthetics, and there was no strong evidence supporting their drug choices.

Spironolactone in anti-acne cream can cause allergic skin reactions in some people.

The document concludes that various hair and scalp disorders in children have specific treatments and proper diagnosis is essential.

The document concludes that scalp disorders can be treated with hair washing, specific shampoos, medications, and sometimes surgery or hair transplants, but hereditary baldness is untreatable.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.